{
    "2021-03-30": [
        [
            {
                "time": "2021-03-30",
                "original_text": "医药行业“送水人”泰格医药发布2020年报 净利同比增长107.9%至17.5亿元",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "年报",
                        "净利增长",
                        "107.9%",
                        "17.5亿元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-30",
                "original_text": "泰格医药：在手订单充足 期待全球市场突破",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "在手订单",
                        "全球市场",
                        "突破"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-30",
                "original_text": "【异动股】泰格医药(03347-HK)涨4.65%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "异动股",
                        "涨4.65%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-30",
                "original_text": "华金证券 - 泰格医药:业绩略超预期，2021年收入有望保持高速增长",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "业绩超预期",
                        "2021年",
                        "高速增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-30",
                "original_text": "高瓴资本概念股普遍强势，公牛、良品铺子、健帆、凯莱英、泰格涨幅居前",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "泰格",
                        "涨幅居前"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-30",
                "original_text": "国元证券给予泰格医药买入评级，泰格医药2020年报点评：疫情恢复良好，在手订单提速",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "买入评级",
                        "疫情恢复",
                        "在手订单提速"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-30",
                "original_text": "【浙商|孙建】泰格医药：主业强劲增长，期待国际化进展",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "主业强劲增长",
                        "国际化进展"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-30",
                "original_text": "专注临床研究和注册申报的“卖水人”，做的竟是「富士康」的买卖",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "临床研究",
                        "注册申报",
                        "卖水人",
                        "富士康"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-30",
                "original_text": "国盛证券 - 泰格医药：业绩符合预期，国际化步伐持续加速",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "业绩符合预期",
                        "国际化加速"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-30",
                "original_text": "创新驱动，赋能研发：泰格医药发布2020年度报告",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "创新驱动",
                        "赋能研发",
                        "2020年度报告"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}